Introduction: Current WHO guidelines consider that under adequate iodine intake <3% of newborns should have neonatal TSH levels of >5 mU/l blood when screening is performed in cord blood or at 3 days to 3 weeks of age. Objective: To estimate whether this absolute criterion when applied to newborns older than 48 h of age and native to Buenos Aires coincides with the traditional ones (goiter and urinary iodine in school-age children (SAC)), and if the evaluation varies with either the methodology used for TSH measurements and/or the time of specimen sampling. Population and Methods: TSH was measured by an immunofluorometric assay (IFMA) on filter paper blood spots of 186 cord blood samples, 112 babies <48 h of age and 1,500 newborns >48 h of age, and by immunoradiometric assay (IRMA) in 238 newborns. The WHO ICCIDD absolute criteria were applied to each population. Thyroid volume was assessed by direct palpation in 500 SAC, and in 100 of them urinary iodine levels were measured. Results: TSH levels were >5 mU/l blood in 11.3% of the cord blood samples and in 3.6% of the samples from babies <48 h of age, suggesting mild iodine deficiency. TSH was >5 mU/l in 2.7% of newborns >48 h of age tested by IFMA (iodine sufficient) and in 30% measured by IRMA (moderate iodine insufficiency). Median urinary iodine and goiter prevalence in SAC were 143 µg/l and 4.5%, respectively, as expected in an iodine-sufficient area. Conclusion: The TSH levels in Buenos Aires conform with the WHO criterion that defines iodine sufficiency. Application of this criterion, however, to cord blood samples or samples from babies <48 h old and the use of different methodologies may lead to erroneous conclusions.

Keywords:
Thyroid-stimulating hormone, neonatal, Iodine deficiency, Urinary iodine, Goiter, Congenital hypothyroidism screening
1.
Hetzel BS, Potter BJ, Dulberg I: The iodine deficiency disorders: Nature, pathogenesis and epidemiology; in Bourne GH (ed): Aspects of Some Vitamins, Minerals and Enzymes in Health and Disease. World Rev Nutr Diet. Basel, Karger, 1990, vol 62, pp 59–119.
2.
Dunn JT: Endemic goiter and cretinism: An update on iodine status. J Pediatr Endocrinol Metab 2001;14:1469–1473.
3.
Delange F: Iodine deficiency; in Braverman LE, Utiger RD (eds): The Thyroid. A Fundamental and Clinical Text, ed 8. Philadelphia, Lippincott Williams & Wilkins, 2000, pp 295–316.
4.
Morreale de Escobar G: The role of thyroid hormone in fetal neurodevelopment. J Pediatr Endocrinol Metab 2001;14:1453–1462.
5.
Delange F, Bourdoux P, Ermans AM: Neonatal thyroid screening used as an index of an extraphysiological supply of iodine; in Hall R, Köbberling J (eds): Thyroid Disorders Associated with Iodine Deficiency and Excess. New York, Raven Press, 1985, pp 273–282.
6.
Bleichrodt N, Born MA: Meta-analysis of research on iodine and its relationship to cognitive development; in Stanbury JB (ed): The Damaged Brain of Iodine Deficiency. New York, Cognizant Communication, 1994, pp 195–200.
7.
World Health Organization, United Nations Children’s Fund: International Council for Control of Iodine Deficiency Disorders. Indicators for Assessing Iodine Deficiency Disorders and Their Control through Salt Iodization. WHO NUT/94. Geneva, World Health Organization, 1994, pp 1–55.
8.
Delange F: Neonatal screening for congenital hypothyroidism: Results and perspectives. Horm Res 1997;48:51–61.
9.
Delange F: Screening for congenital hypothyroidism used as indicator of iodine deficiency and its control. Thyroid 1998;8:1185–1192.
10.
Gruñeiro Papendieck L, Chiesa A, Prieto L, Bengolea S, Perez A, Las Rosa A, Serjan A, Tavosnanska J, Bergadá C: Early newborn screening for congenital hypothyroidism: TSH levels in the first 48 h of life. Screening 1995;4:149–154.
11.
Vela M, Gamboa S, Loera-Luna A, et al: Neonatal screening for congenital hypothyroidism in Mexico: Experience, obstacles and strategies. J Med Screen 1999;6:77–79.
12.
Peterson S, Sanga A, Eklöf H, Bunga B, Taube A, Gebre Medhin M, Rosling H: Classification of thyroid size by palpation and ultrasonography in fields survey. Lancet 2000;355:106–110.
13.
Dunn JT, Medeiros Neto GA: Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, Pan American Health Organization, 1974, publ No 292, pp 1–195.
14.
Sandell EB, Kolthoff M: Microdetermination of iodine by catalytic method. Mikrochem Acta 1937;1:9–15.
15.
Dunn JT, Crutchfield HE, Gutekunst R, Dunn AD: Two simple methods for measuring iodide in urine. Thyroid 1993;3:119–123.
16.
Lavado R, Ausó E, Escobar del Rey F, Morreale de Escobar G, Herbel P: Hypothyroxinemia, induced by low iodine diet, alters cortical cell migration in rats: An experimental model for human neurological cretinism (abstract 121). Eur J Neurosci 2000(suppl 11):43.
17.
Rajatanavin R, Unachak K, Winichakoon P, Chailurkit L, Vilasdechanon N, Tananchai P, Srinawat S: Neonatal thyrotropin profile as an index for severity of iodine deficiency and surveillance of iodine prophylactic program. Thyroid 1997;7:599–604.
18.
Kung AWC, Lao TT, Low LCK, Pang RWC, Robinson JD: Iodine insufficiency and neonatal hyperthyrotropinaemia in Hong Kong. Clin Endocrinol (Oxf) 1997;46:315–319.
19.
Sullivan KM, May W, Nordenberg D, Houston R, Maberly GF: Use of thyroid stimulating hormone testing in newborns to identify iodine deficiency. J Nutr 1997;127:55–58.
20.
Nordenberg D, Sullivan K, Maberly G, Wiley V, Wicken B, Bamforth F, Jenkins M, Hannon H, Adam B: Congenital hypothyroid screening programs and the sensitive thyrotropin assay: Strategies for the surveillance of iodine deficiency disorders; in Delange F, Dunn J, Glinoer D (eds): Iodine Deficiency in Europe: A Continuing Concern. New York, Plenum Press, 1993, pp 211–212.
21.
Delange F, Bürgi H, Chen ZP, Dunn JT: World status of monitoring of iodine deficiency disorders control programs. Thyroid 2002;12:915–924.
22.
Prieto L, Gruñeiro Papendieck L, Chiesa A, Bergadá C: Screening for congenital hypothyroidism (CH) experience in cord blood; in Levy HL, Hermos RJ, Grady GF (eds): Proceedings of the 3rd Meeting of the International Society for Neonatal Screening. New England Regional Newborn Screening Program, Boston, 1996, pp 271–272.
23.
Tuuminen TT, Tsukerman G, Dhondt JL: Population based differences in thyrotropin and thyroxine distributions – Revelation from independent reagents evaluations; in Levy HL, Hermos RJ, Guedy GF (eds): Proceedings of the 3rd Meeting of the International Society for Neonatal Screening. New England Regional Newborn Screening Program, Boston, 1996, pp 248–249.
24.
Tuuminen T, Tsukerman G, Dhondt JL: Population based differences in thyrotropin and thyroxine distributions in healthy newborns revealing results for independent reagents. Eur J Clin Chem Clin Biochem 1996;34:565–568.
25.
McElduff A, McElduff P, Gunton JE, Hams G, Wiley V, Wilcken BM: Neonatal thyroid-stimulating hormone concentrations in northern Sidney: Further indication of mild iodine deficiency. Med J Aust 2002;176:317–320.
26.
Center for Disease Control and Prevention: Newborn Screening Quality Assurance Programs. Atlanta, CDC, 2000;17:4.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.